Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 921–930 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 921
- Medicine slug
- medroxyprogesterone
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 37
- Source count
- 15
- Agreement rate
- 1
- Recorded readings
86%
- Numeric value
- 86
- Unit
- %
- Source records
- 15
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 15 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1ea4098-6196-421f-b8e1-bcb31a061e04 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:390087a6-f3c3-4f0b-a930-79acf412f153 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Figure P Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6457d70a-2f25-4935-8511-726d988f7a03 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0476eac5-d96c-4910-aa86-1ddeeefefe50 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fda1aa8a-5739-482a-b4f6-9741ef4d9977 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60aba812-59eb-4d40-9b6b-d135dca9d36b (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e817926-ba15-4d16-9463-88f6ff3bd3ac (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of medroxyprogesterone acetate averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca344c55-5251-470f-9243-eceb9e496e3e (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of medroxyprogesterone acetate averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01e28bef-9758-40cf-a4ff-86ae9f4f5105 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:987496bf-b4b0-409b-b745-f52ed0871f4e (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of medroxyprogesterone acetate averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:199cf13e-0859-4a73-9b45-e700d0cd1049 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a80560e1-96dd-4380-b3e1-d52719ccdd4b (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0655670a-d127-4e08-8a23-ace64b2503b2 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24544a5d-0cf5-a099-b57c-6e0843a40532 (opens source in a new tab)
Medroxyprogesterone label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of MPA averages 86%.
Projected row 922
- Medicine slug
- mefenamic-acid
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 6
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
2 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e927779-411a-b5f5-e063-6394a90aae93 (opens source in a new tab)
Mefenamic Acid label
Version not recorded · Effective date not recorded
Peak plasma levels are attained in 2 to 4 hours and the elimination half-life approximates 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0291319-ab3e-20c8-e053-2a95a90afabb (opens source in a new tab)
Mefenamic Acid label
Version not recorded · Effective date not recorded
Peak plasma levels are attained in 2 to 4 hours and the elimination half-life approximates 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8b1a4a2-83fc-6b4b-e053-6394a90ac46a (opens source in a new tab)
Mefenamic Acid label
Version not recorded · Effective date not recorded
Peak plasma levels are attained in 2 to 4 hours and the elimination half-life approximates 2 hours.
Projected row 923
- Medicine slug
- mefenamic-acid
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 6
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
8 hours
- Numeric value
- 8
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e927779-411a-b5f5-e063-6394a90aae93 (opens source in a new tab)
Mefenamic Acid label
Version not recorded · Effective date not recorded
The mean time to maximum concentration (T max ) was 8 hours (range 2 to 18 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0291319-ab3e-20c8-e053-2a95a90afabb (opens source in a new tab)
Mefenamic Acid label
Version not recorded · Effective date not recorded
The mean time to maximum concentration (T max ) was 8 hours (range 2-18 hrs). 11 Race Pharmacokinetic differences due to race have not been identified.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8b1a4a2-83fc-6b4b-e053-6394a90ac46a (opens source in a new tab)
Mefenamic Acid label
Version not recorded · Effective date not recorded
The mean time to maximum concentration (T max) was 8 hours (range 2 to 18 hours).
Projected row 924
- Medicine slug
- mefloquine
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 3
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
98%
- Numeric value
- 98
- Unit
- %
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cbe26c7-7313-4cd6-9514-9190af1de763 (opens source in a new tab)
Mefloquine label
Version not recorded · Effective date not recorded
Protein binding is about 98%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09716a24-d7da-42b2-af29-c03a1b6670bd (opens source in a new tab)
Mefloquine label
Version not recorded · Effective date not recorded
Protein binding is about 98%.
Projected row 925
- Medicine slug
- mefloquine
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 3
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
20 L/kg
- Numeric value
- 20
- Unit
- L/kg
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cbe26c7-7313-4cd6-9514-9190af1de763 (opens source in a new tab)
Mefloquine label
Version not recorded · Effective date not recorded
Distribution: In healthy adults, the apparent volume of distribution is approximately 20 L/kg, indicating extensive tissue distribution.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09716a24-d7da-42b2-af29-c03a1b6670bd (opens source in a new tab)
Mefloquine label
Version not recorded · Effective date not recorded
Distribution: In healthy adults, the apparent volume of distribution is approximately 20 L/kg, indicating extensive tissue distribution.
Projected row 926
- Medicine slug
- megestrol
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 21
- Source count
- 7
- Agreement rate
- 0.428571
- Recorded readings
13.0 to 104.9 hours
- Numeric value
- 13
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ec70070-da70-4a38-9d58-cf2278517661 (opens source in a new tab)
Megestrol label
Version not recorded · Effective date not recorded
Plasma elimination half-life ranged from 13.0 to 104.9 hours (mean 34.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c755c6b-32e9-4029-8b70-855007f7375b (opens source in a new tab)
Megestrol label
Version not recorded · Effective date not recorded
Plasma elimination half-life ranged from 13.0 to 104.9 hours (mean 34.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd6617df-0876-4fc5-8435-b53d29ccc1ae (opens source in a new tab)
Megestrol label
Version not recorded · Effective date not recorded
Plasma elimination half-life ranged from 13.0 to 104.9 hours (mean 34.2 hours).
13 to 104.9 hours
- Numeric value
- 13
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b764cf3-4756-4f0e-b747-421d71674313 (opens source in a new tab)
Megestrol label
Version not recorded · Effective date not recorded
Plasma elimination half-life ranged from 13 to 104.9 hours (mean 34.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66573d39-f2a7-49fd-9ed2-97ac8f6e8456 (opens source in a new tab)
Megestrol label
Version not recorded · Effective date not recorded
Plasma elimination half-life ranged from 13 to 104.9 hours (mean 34.2 hours).
20 to 50 hours
- Numeric value
- 20
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2dc921d5-e423-4379-a345-151e87d13651 (opens source in a new tab)
Megestrol label
Version not recorded · Effective date not recorded
The mean elimination half-life of megestrol ranged from 20 to 50 hours in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6342df31-afce-4deb-b992-e08e2a4b2b77 (opens source in a new tab)
Megestrol label
Version not recorded · Effective date not recorded
The mean elimination half-life of megestrol ranged from 20 to 50 hours in healthy subjects.
Projected row 927
- Medicine slug
- meloxicam
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 122
- Source count
- 117
- Agreement rate
- 1
- Recorded readings
89%
- Numeric value
- 89
- Unit
- %
- Source records
- 117
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 117 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdd282df-572f-42a7-a1c6-a00e1bb4573d (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9ce58c-3cd7-769f-e053-2a95a90a5385 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfaac71c-dcc5-4b57-bf3b-616fccab96de (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a381942f-0cba-4e97-4741-ad04a6af2164 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa28251e-cab0-49a2-bf3f-ad820b1432cf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20ec4646-9d1c-41c9-93f6-754b3a4f234f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe41eca5-33f1-4ded-a177-d8f927f3f261 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2875c30d-508a-46e1-ae5a-bc7057e7cbee (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:459bd9c0-1102-46d3-8020-5fec80d1ec36 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55af77dd-2abc-49a6-990c-399d5a5e7a91 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffaf1db4-25a9-48d1-a624-242f9d8e14c7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5407aded-9f84-72ce-e063-6394a90ae672 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56440abd-80f4-7b8d-e063-6394a90a2a91 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:438311de-78e7-8bd9-e063-6394a90a7932 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0edec862-f3e8-46f6-b6d0-de0bc21dd3fb (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7df126c1-a729-4bfe-9d08-ad359c9ee3bc (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29974b41-68b4-42cf-8835-18ae480c2952 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2eaac8b2-d50a-a0bc-e063-6294a90a7cac (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11984306-9b71-4c2a-81bc-8942966810be (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ddf5a4d-8e84-419d-8e3a-c91b85501885 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548ec3b7-2b6d-cd9e-e063-6394a90a78ff (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8c35ea4-d6ac-40c7-8f35-864fd1ec75d2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7048d6cc-88a7-4743-8481-63a2005fa27a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eae60d2c-411c-460a-b673-05b5784ed943 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:445d7cbf-bd3e-a54f-e063-6294a90a67a5 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5265e241-ab6a-400f-809f-5992f36c5593 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5d72a30-3d32-45ad-be81-3fe601d8912b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e37bece-b23e-41ca-9557-5105087e273b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29b9c956-4146-6941-e063-6394a90aa3c8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cf496-d505-f2ba-e053-2995a90a76cf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3182622-4b9b-4850-bf9f-108c5610eb40 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6f37980-8e09-4f2e-a768-b3d22cbe3d49 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:820f143f-4b0c-4466-be9a-212dab9d984b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5d153147-f1c8-4624-8028-fe84680d7143 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dbce26-b2ac-2ce4-e063-6294a90a5727 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac58edaa-4aba-4fa8-9ccd-f33477aee218 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:432c3937-a4fe-4c92-8452-9ed2dd2cfc9a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10c3949c-0066-4b8a-8d35-937e1ce09bf8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c015f72-5ce3-4f56-8237-776fc2165b0c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5e12448-1ca1-46a4-8de4-e8b94567e5a8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b1938e5-7a9e-b214-e063-6394a90a1270 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19c13159-71f1-2427-e063-6394a90ad44e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f31d181a-33cb-560f-e053-2995a90abbd9 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d27feaf7-731e-1a8f-e053-2a95a90afa71 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1160b6a8-d507-40b6-925b-25bf186daa30 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5488ccc1-e416-e5d7-e063-6294a90a6cb8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d8b617a-b9b3-473c-be9b-f34a585a1b3b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87ef5a9b-2dd1-2ef9-e053-2995a90a5149 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:218e71c6-265a-45f4-b660-5c1da5a36bd2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bcfca8c6-bdba-4546-97be-1fc5601c7346 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f43b954-d1cb-4210-b479-5292c446cc74 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49367275-4bff-4e36-8a91-e59eb07aa15f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9392df66-a152-40e6-b43b-44dc46a23496 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:630221ef-714e-6996-e053-2991aa0a586f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5860527-f338-4073-9bb4-9f5f079469e7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ce43f4a-c525-4ce1-b328-514b3912e305 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdb998b4-093f-45de-90eb-a3dc03dbfd1e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52bd9bcd-4902-f9dd-e063-6294a90a604e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0deb1f7-b575-463f-a3f8-304cc1936075 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66bc3f93-a73b-476c-83d4-7354d2e18575 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dcbc65-d126-7b48-e063-6294a90a52e9 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7895f389-1509-4e03-8668-526ab1627fc8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06a401f0-4380-4081-86ed-a309a25abf6b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75af3e09-f510-45a4-9f21-50bff7aa5510 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d7ede5a-c12e-4979-a47a-f3346ea5bc80 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1c2d65f-ebb1-48bf-8fa1-c216f7d570ec (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cc0c4c2-eac9-4820-942a-6c606dfb4aa1 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fabd063a-d3a5-44a3-90a2-e33d721b7a95 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e8a6283-1e1b-4199-ac73-f42255c7e907 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548ef3ed-ab67-ec85-e063-6294a90ab1da (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ab45be4-b2b9-4374-95ab-620e0f90fb70 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cb78a-e61b-b099-e053-2a95a90a3ad8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f93806e1-88b8-4bcd-ac29-7642ab4d6cbd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ede6724-d9be-5b44-e063-6294a90afbaa (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:445dc4f6-daac-e2f1-e063-6394a90a0ca5 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ff222f1-3fe2-9591-e063-6394a90a349f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14e7472a-24fe-4ae1-abc7-c2972ce8cd74 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b42bdc-47e1-19c5-e053-2a95a90a1828 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20871c7f-1e36-49ef-8e2b-70112430ca1e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b710b959-a64d-a631-e053-2995a90a2177 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b603255e-1fcf-42ec-ab62-9aa321cb7ac6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43ca4ab6-7d52-2954-e054-00144ff88e88 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1603665-bbce-48b3-9424-3646570ae9b8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:966ae650-ad7d-4de1-ab06-54992408fcfd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5fe76337-eae5-4e5c-96ef-6cfa97983c6e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50ecda86-d46b-4a78-b423-879f9f5c42bd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c51a641b-5715-4be9-baac-7fd4ec729570 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4acea0aa-973f-40e5-88b4-0e2d85ea624c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4dc34489-cbb6-4e57-a2cc-a274209456f3 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:453c5328-090e-0159-e063-6394a90a06b7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5071e1fd-5321-42cf-e063-6294a90a0ef6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:385b7cf4-976a-4a58-9ebc-def8b6e78b75 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee8df8fa-d08a-8c8b-f048-813e5022a101 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef3447a9-ed6a-4cba-9681-09ae9dc8b630 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4925f194-c924-242c-e054-00144ff88e88 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cde70-6c74-f6a8-e053-2995a90addaf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb83cd61-0a82-4fe0-b72e-5b715cbd656d (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:937ea2ca-6b8c-4c80-9926-f4de7c8f5643 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a4212a8-7761-4a77-aa18-ecf1f1244df2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60c9ab35-4b6e-383d-e053-2a91aa0a26ad (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbe71312-0f9d-47c1-e053-6394a90a63a1 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:108397e9-672d-4061-bb74-65818c782d61 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f210e6b4-43b3-4d33-bc0b-013a0f907d3e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:702a4aa6-a588-48db-9cc5-74ae417f9587 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3cc9741f-0574-485f-bbf5-027cb236736c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb5834e0-c6db-4d0f-ae37-9ba2e1aabfdf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37c030e7-f4f0-4923-847e-85325265960a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25b742d8-5a95-9ec8-e063-6294a90a89ae (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b33bf17a-3134-6f32-e053-2a95a90a261b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67974608-326e-4e62-8430-6fbc14d1d69b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bd53770-7077-49c7-8215-73a17a20ea70 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c172a767-eb26-4995-b2a2-f3c5e87b4943 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
It is not completely understood how reduced synthesis of these compounds results in therapeutic efficacy. 12.2 Pharmacodynamics Meloxicam exhibits anti-inflammatory, analgesic, and antipyretic activities. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60c954d5-bd5a-33f9-e053-2a91aa0ab597 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68b50c82-7130-428a-884c-98576887e99a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Because meloxicam is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues. 12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58d34e5d-4efb-3d76-e063-6394a90aa0f6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of meloxicam capsules was 89% following a single oral dose of 30 mg compared with 30 mg IV bolus injection.
Projected row 928
- Medicine slug
- meloxicam
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 122
- Source count
- 121
- Agreement rate
- 0.966942
- Recorded readings
15 hours
- Numeric value
- 15
- Unit
- hours
- Source records
- 117
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 117 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdd282df-572f-42a7-a1c6-a00e1bb4573d (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9ce58c-3cd7-769f-e053-2a95a90a5385 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfaac71c-dcc5-4b57-bf3b-616fccab96de (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a381942f-0cba-4e97-4741-ad04a6af2164 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20ec4646-9d1c-41c9-93f6-754b3a4f234f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe41eca5-33f1-4ded-a177-d8f927f3f261 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2875c30d-508a-46e1-ae5a-bc7057e7cbee (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:459bd9c0-1102-46d3-8020-5fec80d1ec36 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55af77dd-2abc-49a6-990c-399d5a5e7a91 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffaf1db4-25a9-48d1-a624-242f9d8e14c7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5407aded-9f84-72ce-e063-6394a90ae672 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56440abd-80f4-7b8d-e063-6394a90a2a91 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:438311de-78e7-8bd9-e063-6394a90a7932 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0edec862-f3e8-46f6-b6d0-de0bc21dd3fb (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7df126c1-a729-4bfe-9d08-ad359c9ee3bc (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29974b41-68b4-42cf-8835-18ae480c2952 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2eaac8b2-d50a-a0bc-e063-6294a90a7cac (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11984306-9b71-4c2a-81bc-8942966810be (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ddf5a4d-8e84-419d-8e3a-c91b85501885 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548ec3b7-2b6d-cd9e-e063-6394a90a78ff (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8c35ea4-d6ac-40c7-8f35-864fd1ec75d2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7048d6cc-88a7-4743-8481-63a2005fa27a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eae60d2c-411c-460a-b673-05b5784ed943 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:445d7cbf-bd3e-a54f-e063-6294a90a67a5 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5265e241-ab6a-400f-809f-5992f36c5593 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5d72a30-3d32-45ad-be81-3fe601d8912b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e37bece-b23e-41ca-9557-5105087e273b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29b9c956-4146-6941-e063-6394a90aa3c8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cf496-d505-f2ba-e053-2995a90a76cf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3182622-4b9b-4850-bf9f-108c5610eb40 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6f37980-8e09-4f2e-a768-b3d22cbe3d49 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:820f143f-4b0c-4466-be9a-212dab9d984b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5d153147-f1c8-4624-8028-fe84680d7143 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dbce26-b2ac-2ce4-e063-6294a90a5727 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac58edaa-4aba-4fa8-9ccd-f33477aee218 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:432c3937-a4fe-4c92-8452-9ed2dd2cfc9a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10c3949c-0066-4b8a-8d35-937e1ce09bf8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c015f72-5ce3-4f56-8237-776fc2165b0c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5e12448-1ca1-46a4-8de4-e8b94567e5a8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b1938e5-7a9e-b214-e063-6394a90a1270 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19c13159-71f1-2427-e063-6394a90ad44e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f31d181a-33cb-560f-e053-2995a90abbd9 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d27feaf7-731e-1a8f-e053-2a95a90afa71 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1160b6a8-d507-40b6-925b-25bf186daa30 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5488ccc1-e416-e5d7-e063-6294a90a6cb8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d8b617a-b9b3-473c-be9b-f34a585a1b3b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87ef5a9b-2dd1-2ef9-e053-2995a90a5149 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:218e71c6-265a-45f4-b660-5c1da5a36bd2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bcfca8c6-bdba-4546-97be-1fc5601c7346 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f43b954-d1cb-4210-b479-5292c446cc74 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49367275-4bff-4e36-8a91-e59eb07aa15f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9392df66-a152-40e6-b43b-44dc46a23496 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:630221ef-714e-6996-e053-2991aa0a586f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5860527-f338-4073-9bb4-9f5f079469e7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ce43f4a-c525-4ce1-b328-514b3912e305 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdb998b4-093f-45de-90eb-a3dc03dbfd1e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52bd9bcd-4902-f9dd-e063-6294a90a604e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0deb1f7-b575-463f-a3f8-304cc1936075 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66bc3f93-a73b-476c-83d4-7354d2e18575 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dcbc65-d126-7b48-e063-6294a90a52e9 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7895f389-1509-4e03-8668-526ab1627fc8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06a401f0-4380-4081-86ed-a309a25abf6b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75af3e09-f510-45a4-9f21-50bff7aa5510 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d7ede5a-c12e-4979-a47a-f3346ea5bc80 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1c2d65f-ebb1-48bf-8fa1-c216f7d570ec (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cc0c4c2-eac9-4820-942a-6c606dfb4aa1 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fabd063a-d3a5-44a3-90a2-e33d721b7a95 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e8a6283-1e1b-4199-ac73-f42255c7e907 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548ef3ed-ab67-ec85-e063-6294a90ab1da (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ab45be4-b2b9-4374-95ab-620e0f90fb70 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cb78a-e61b-b099-e053-2a95a90a3ad8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f93806e1-88b8-4bcd-ac29-7642ab4d6cbd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ede6724-d9be-5b44-e063-6294a90afbaa (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:445dc4f6-daac-e2f1-e063-6394a90a0ca5 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ff222f1-3fe2-9591-e063-6394a90a349f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14e7472a-24fe-4ae1-abc7-c2972ce8cd74 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b42bdc-47e1-19c5-e053-2a95a90a1828 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20871c7f-1e36-49ef-8e2b-70112430ca1e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b710b959-a64d-a631-e053-2995a90a2177 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b603255e-1fcf-42ec-ab62-9aa321cb7ac6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43ca4ab6-7d52-2954-e054-00144ff88e88 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1603665-bbce-48b3-9424-3646570ae9b8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:966ae650-ad7d-4de1-ab06-54992408fcfd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5fe76337-eae5-4e5c-96ef-6cfa97983c6e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50ecda86-d46b-4a78-b423-879f9f5c42bd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c51a641b-5715-4be9-baac-7fd4ec729570 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4acea0aa-973f-40e5-88b4-0e2d85ea624c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4dc34489-cbb6-4e57-a2cc-a274209456f3 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:453c5328-090e-0159-e063-6394a90a06b7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5071e1fd-5321-42cf-e063-6294a90a0ef6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:385b7cf4-976a-4a58-9ebc-def8b6e78b75 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee8df8fa-d08a-8c8b-f048-813e5022a101 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef3447a9-ed6a-4cba-9681-09ae9dc8b630 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4925f194-c924-242c-e054-00144ff88e88 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9d0426-9cbb-a6a3-e053-2995a90aed2f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cde70-6c74-f6a8-e053-2995a90addaf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb83cd61-0a82-4fe0-b72e-5b715cbd656d (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:937ea2ca-6b8c-4c80-9926-f4de7c8f5643 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a4212a8-7761-4a77-aa18-ecf1f1244df2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60c9ab35-4b6e-383d-e053-2a91aa0a26ad (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbe71312-0f9d-47c1-e053-6394a90a63a1 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:108397e9-672d-4061-bb74-65818c782d61 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f210e6b4-43b3-4d33-bc0b-013a0f907d3e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:702a4aa6-a588-48db-9cc5-74ae417f9587 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3cc9741f-0574-485f-bbf5-027cb236736c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb5834e0-c6db-4d0f-ae37-9ba2e1aabfdf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37c030e7-f4f0-4923-847e-85325265960a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25b742d8-5a95-9ec8-e063-6294a90a89ae (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b33bf17a-3134-6f32-e053-2a95a90a261b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67974608-326e-4e62-8430-6fbc14d1d69b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bd53770-7077-49c7-8215-73a17a20ea70 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c172a767-eb26-4995-b2a2-f3c5e87b4943 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60c954d5-bd5a-33f9-e053-2a91aa0ab597 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68b50c82-7130-428a-884c-98576887e99a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) ranges from 15 hours to 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58d34e5d-4efb-3d76-e063-6394a90aa0f6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) ranges from 15 hours to 20 hours.
21 hours
- Numeric value
- 21
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf2b198c-0726-488a-b911-4fe394e4b56e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) for XIFYRM 30 mg is approximately 21 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:385fd779-1be1-49ae-8213-750b96ecc997 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) for QAMZOVA 30 mg is approximately 21 hours.
22 hours
- Numeric value
- 22
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce9a8fd7-9bd2-4793-82f3-0fb8f0965d0f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t1/2) for meloxicam 5 mg and 10 mg is approximately 22 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43e2b0f3-cf34-4f51-aa93-39ed98cab449 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
The mean elimination half-life (t 1/2 ) for meloxicam capsules 5 mg and 10 mg is approximately 22 hours.
Projected row 929
- Medicine slug
- meloxicam
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 122
- Source count
- 80
- Agreement rate
- 1
- Recorded readings
7 hours
- Numeric value
- 7
- Unit
- hours
- Source records
- 80
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 80 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdd282df-572f-42a7-a1c6-a00e1bb4573d (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe41eca5-33f1-4ded-a177-d8f927f3f261 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2875c30d-508a-46e1-ae5a-bc7057e7cbee (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55af77dd-2abc-49a6-990c-399d5a5e7a91 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5407aded-9f84-72ce-e063-6394a90ae672 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7df126c1-a729-4bfe-9d08-ad359c9ee3bc (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29974b41-68b4-42cf-8835-18ae480c2952 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2eaac8b2-d50a-a0bc-e063-6294a90a7cac (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ddf5a4d-8e84-419d-8e3a-c91b85501885 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548ec3b7-2b6d-cd9e-e063-6394a90a78ff (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8c35ea4-d6ac-40c7-8f35-864fd1ec75d2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7048d6cc-88a7-4743-8481-63a2005fa27a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eae60d2c-411c-460a-b673-05b5784ed943 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:445d7cbf-bd3e-a54f-e063-6294a90a67a5 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5265e241-ab6a-400f-809f-5992f36c5593 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5d72a30-3d32-45ad-be81-3fe601d8912b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29b9c956-4146-6941-e063-6394a90aa3c8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cf496-d505-f2ba-e053-2995a90a76cf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3182622-4b9b-4850-bf9f-108c5610eb40 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dbce26-b2ac-2ce4-e063-6294a90a5727 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac58edaa-4aba-4fa8-9ccd-f33477aee218 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10c3949c-0066-4b8a-8d35-937e1ce09bf8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c015f72-5ce3-4f56-8237-776fc2165b0c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b1938e5-7a9e-b214-e063-6394a90a1270 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19c13159-71f1-2427-e063-6394a90ad44e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f31d181a-33cb-560f-e053-2995a90abbd9 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d27feaf7-731e-1a8f-e053-2a95a90afa71 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1160b6a8-d507-40b6-925b-25bf186daa30 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5488ccc1-e416-e5d7-e063-6294a90a6cb8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87ef5a9b-2dd1-2ef9-e053-2995a90a5149 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:218e71c6-265a-45f4-b660-5c1da5a36bd2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bcfca8c6-bdba-4546-97be-1fc5601c7346 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f43b954-d1cb-4210-b479-5292c446cc74 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5860527-f338-4073-9bb4-9f5f079469e7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdb998b4-093f-45de-90eb-a3dc03dbfd1e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52bd9bcd-4902-f9dd-e063-6294a90a604e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0deb1f7-b575-463f-a3f8-304cc1936075 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66bc3f93-a73b-476c-83d4-7354d2e18575 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dcbc65-d126-7b48-e063-6294a90a52e9 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7895f389-1509-4e03-8668-526ab1627fc8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06a401f0-4380-4081-86ed-a309a25abf6b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75af3e09-f510-45a4-9f21-50bff7aa5510 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d7ede5a-c12e-4979-a47a-f3346ea5bc80 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1c2d65f-ebb1-48bf-8fa1-c216f7d570ec (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cc0c4c2-eac9-4820-942a-6c606dfb4aa1 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fabd063a-d3a5-44a3-90a2-e33d721b7a95 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548ef3ed-ab67-ec85-e063-6294a90ab1da (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ab45be4-b2b9-4374-95ab-620e0f90fb70 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f93806e1-88b8-4bcd-ac29-7642ab4d6cbd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ede6724-d9be-5b44-e063-6294a90afbaa (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:445dc4f6-daac-e2f1-e063-6394a90a0ca5 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b42bdc-47e1-19c5-e053-2a95a90a1828 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20871c7f-1e36-49ef-8e2b-70112430ca1e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b710b959-a64d-a631-e053-2995a90a2177 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b603255e-1fcf-42ec-ab62-9aa321cb7ac6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43ca4ab6-7d52-2954-e054-00144ff88e88 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1603665-bbce-48b3-9424-3646570ae9b8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:966ae650-ad7d-4de1-ab06-54992408fcfd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50ecda86-d46b-4a78-b423-879f9f5c42bd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c51a641b-5715-4be9-baac-7fd4ec729570 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:453c5328-090e-0159-e063-6394a90a06b7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5071e1fd-5321-42cf-e063-6294a90a0ef6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:385b7cf4-976a-4a58-9ebc-def8b6e78b75 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee8df8fa-d08a-8c8b-f048-813e5022a101 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9d0426-9cbb-a6a3-e053-2995a90aed2f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cde70-6c74-f6a8-e053-2995a90addaf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb83cd61-0a82-4fe0-b72e-5b715cbd656d (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:937ea2ca-6b8c-4c80-9926-f4de7c8f5643 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a4212a8-7761-4a77-aa18-ecf1f1244df2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbe71312-0f9d-47c1-e053-6394a90a63a1 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:108397e9-672d-4061-bb74-65818c782d61 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:702a4aa6-a588-48db-9cc5-74ae417f9587 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3cc9741f-0574-485f-bbf5-027cb236736c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37c030e7-f4f0-4923-847e-85325265960a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25b742d8-5a95-9ec8-e063-6294a90a89ae (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b33bf17a-3134-6f32-e053-2a95a90a261b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the Cmax values for meloxicam suspension were affected following a similar high fat meal, while mean Tmax values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bd53770-7077-49c7-8215-73a17a20ea70 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58d34e5d-4efb-3d76-e063-6394a90aa0f6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
In comparison, neither the AUC nor the C max values for meloxicam suspension were affected following a similar high fat meal, while mean T max values were increased to approximately 7 hours.
Projected row 930
- Medicine slug
- meloxicam
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 122
- Source count
- 121
- Agreement rate
- 0.983471
- Recorded readings
10 L
- Numeric value
- 10
- Unit
- L
- Source records
- 119
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 119 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdd282df-572f-42a7-a1c6-a00e1bb4573d (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9ce58c-3cd7-769f-e053-2a95a90a5385 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfaac71c-dcc5-4b57-bf3b-616fccab96de (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a381942f-0cba-4e97-4741-ad04a6af2164 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20ec4646-9d1c-41c9-93f6-754b3a4f234f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe41eca5-33f1-4ded-a177-d8f927f3f261 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2875c30d-508a-46e1-ae5a-bc7057e7cbee (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:459bd9c0-1102-46d3-8020-5fec80d1ec36 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55af77dd-2abc-49a6-990c-399d5a5e7a91 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffaf1db4-25a9-48d1-a624-242f9d8e14c7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5407aded-9f84-72ce-e063-6394a90ae672 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56440abd-80f4-7b8d-e063-6394a90a2a91 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:438311de-78e7-8bd9-e063-6394a90a7932 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0edec862-f3e8-46f6-b6d0-de0bc21dd3fb (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7df126c1-a729-4bfe-9d08-ad359c9ee3bc (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29974b41-68b4-42cf-8835-18ae480c2952 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2eaac8b2-d50a-a0bc-e063-6294a90a7cac (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce9a8fd7-9bd2-4793-82f3-0fb8f0965d0f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11984306-9b71-4c2a-81bc-8942966810be (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ddf5a4d-8e84-419d-8e3a-c91b85501885 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548ec3b7-2b6d-cd9e-e063-6394a90a78ff (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8c35ea4-d6ac-40c7-8f35-864fd1ec75d2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7048d6cc-88a7-4743-8481-63a2005fa27a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eae60d2c-411c-460a-b673-05b5784ed943 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:445d7cbf-bd3e-a54f-e063-6294a90a67a5 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5265e241-ab6a-400f-809f-5992f36c5593 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5d72a30-3d32-45ad-be81-3fe601d8912b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e37bece-b23e-41ca-9557-5105087e273b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29b9c956-4146-6941-e063-6394a90aa3c8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cf496-d505-f2ba-e053-2995a90a76cf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3182622-4b9b-4850-bf9f-108c5610eb40 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6f37980-8e09-4f2e-a768-b3d22cbe3d49 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:820f143f-4b0c-4466-be9a-212dab9d984b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5d153147-f1c8-4624-8028-fe84680d7143 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dbce26-b2ac-2ce4-e063-6294a90a5727 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac58edaa-4aba-4fa8-9ccd-f33477aee218 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:432c3937-a4fe-4c92-8452-9ed2dd2cfc9a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10c3949c-0066-4b8a-8d35-937e1ce09bf8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c015f72-5ce3-4f56-8237-776fc2165b0c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5e12448-1ca1-46a4-8de4-e8b94567e5a8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b1938e5-7a9e-b214-e063-6394a90a1270 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19c13159-71f1-2427-e063-6394a90ad44e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f31d181a-33cb-560f-e053-2995a90abbd9 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d27feaf7-731e-1a8f-e053-2a95a90afa71 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1160b6a8-d507-40b6-925b-25bf186daa30 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5488ccc1-e416-e5d7-e063-6294a90a6cb8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d8b617a-b9b3-473c-be9b-f34a585a1b3b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87ef5a9b-2dd1-2ef9-e053-2995a90a5149 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:218e71c6-265a-45f4-b660-5c1da5a36bd2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bcfca8c6-bdba-4546-97be-1fc5601c7346 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f43b954-d1cb-4210-b479-5292c446cc74 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49367275-4bff-4e36-8a91-e59eb07aa15f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9392df66-a152-40e6-b43b-44dc46a23496 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:630221ef-714e-6996-e053-2991aa0a586f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5860527-f338-4073-9bb4-9f5f079469e7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ce43f4a-c525-4ce1-b328-514b3912e305 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdb998b4-093f-45de-90eb-a3dc03dbfd1e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52bd9bcd-4902-f9dd-e063-6294a90a604e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0deb1f7-b575-463f-a3f8-304cc1936075 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66bc3f93-a73b-476c-83d4-7354d2e18575 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58dcbc65-d126-7b48-e063-6294a90a52e9 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7895f389-1509-4e03-8668-526ab1627fc8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06a401f0-4380-4081-86ed-a309a25abf6b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75af3e09-f510-45a4-9f21-50bff7aa5510 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d7ede5a-c12e-4979-a47a-f3346ea5bc80 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1c2d65f-ebb1-48bf-8fa1-c216f7d570ec (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cc0c4c2-eac9-4820-942a-6c606dfb4aa1 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fabd063a-d3a5-44a3-90a2-e33d721b7a95 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e8a6283-1e1b-4199-ac73-f42255c7e907 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548ef3ed-ab67-ec85-e063-6294a90ab1da (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ab45be4-b2b9-4374-95ab-620e0f90fb70 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cb78a-e61b-b099-e053-2a95a90a3ad8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f93806e1-88b8-4bcd-ac29-7642ab4d6cbd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ede6724-d9be-5b44-e063-6294a90afbaa (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:445dc4f6-daac-e2f1-e063-6394a90a0ca5 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ff222f1-3fe2-9591-e063-6394a90a349f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14e7472a-24fe-4ae1-abc7-c2972ce8cd74 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b42bdc-47e1-19c5-e053-2a95a90a1828 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20871c7f-1e36-49ef-8e2b-70112430ca1e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b710b959-a64d-a631-e053-2995a90a2177 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b603255e-1fcf-42ec-ab62-9aa321cb7ac6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43ca4ab6-7d52-2954-e054-00144ff88e88 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1603665-bbce-48b3-9424-3646570ae9b8 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:966ae650-ad7d-4de1-ab06-54992408fcfd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5fe76337-eae5-4e5c-96ef-6cfa97983c6e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50ecda86-d46b-4a78-b423-879f9f5c42bd (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c51a641b-5715-4be9-baac-7fd4ec729570 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4acea0aa-973f-40e5-88b4-0e2d85ea624c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4dc34489-cbb6-4e57-a2cc-a274209456f3 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:453c5328-090e-0159-e063-6394a90a06b7 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5071e1fd-5321-42cf-e063-6294a90a0ef6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:385b7cf4-976a-4a58-9ebc-def8b6e78b75 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee8df8fa-d08a-8c8b-f048-813e5022a101 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef3447a9-ed6a-4cba-9681-09ae9dc8b630 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4925f194-c924-242c-e054-00144ff88e88 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9d0426-9cbb-a6a3-e053-2995a90aed2f (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af9cde70-6c74-f6a8-e053-2995a90addaf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb83cd61-0a82-4fe0-b72e-5b715cbd656d (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43e2b0f3-cf34-4f51-aa93-39ed98cab449 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:937ea2ca-6b8c-4c80-9926-f4de7c8f5643 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a4212a8-7761-4a77-aa18-ecf1f1244df2 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60c9ab35-4b6e-383d-e053-2a91aa0a26ad (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbe71312-0f9d-47c1-e053-6394a90a63a1 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:108397e9-672d-4061-bb74-65818c782d61 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f210e6b4-43b3-4d33-bc0b-013a0f907d3e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:702a4aa6-a588-48db-9cc5-74ae417f9587 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3cc9741f-0574-485f-bbf5-027cb236736c (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb5834e0-c6db-4d0f-ae37-9ba2e1aabfdf (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37c030e7-f4f0-4923-847e-85325265960a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25b742d8-5a95-9ec8-e063-6294a90a89ae (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b33bf17a-3134-6f32-e053-2a95a90a261b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67974608-326e-4e62-8430-6fbc14d1d69b (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bd53770-7077-49c7-8215-73a17a20ea70 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (V ss ) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c172a767-eb26-4995-b2a2-f3c5e87b4943 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60c954d5-bd5a-33f9-e053-2a91aa0ab597 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68b50c82-7130-428a-884c-98576887e99a (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58d34e5d-4efb-3d76-e063-6394a90aa0f6 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution (Vss) of meloxicam is approximately 10 L.
9.63 L
- Numeric value
- 9.63
- Unit
- L
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf2b198c-0726-488a-b911-4fe394e4b56e (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution Following administration of meloxicam injection, the apparent volume of distribution during the terminal elimination phase (Vz) of meloxicam is 9.63 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:385fd779-1be1-49ae-8213-750b96ecc997 (opens source in a new tab)
Meloxicam label
Version not recorded · Effective date not recorded
Distribution Following administration of meloxicam injection, the apparent volume of distribution during the terminal elimination phase (Vz) of meloxicam is 9.63 L.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=920Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.